Literature DB >> 14535830

Effect of resveratrol on some activities of isolated and in whole blood human neutrophils.

A Cavallaro1, T Ainis, C Bottari, V Fimiani.   

Abstract

Resveratrol, which is a polyphenol present in red wines and vegetables included in human diets, exerts many biological effects. The aim of the present study was to investigate its effect on some activities of polymorphonuclear leukocytes, particularly the generation of superoxide anion ((O2)(-)) in whole blood, hypochlorous acid (HOCl) and nitric oxide (NO) production by isolated cells, and chemotaxis. Resveratrol showed significant dose-dependent inhibitory effect on all these activities. In particular, it inhibited O2(-) generation in stimulated but not in resting neutrophils, decreased HOCl much more than O2(-) production indicating an effect on myeloperoxidase secretion since HOCl production is directly and proportionally dependent on O2(-) generation and reduced cell motility. The small dose of resveratrol (4.38 nM) used is attainable with a diet including red wine and vegetables confirming its protective role against some pathological processes such as inflammation, coronary heart disease, and cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14535830

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  10 in total

1.  Dose-dependency of resveratrol in providing health benefits.

Authors:  Subhendu Mukherjee; Jocelyn I Dudley; Dipak K Das
Journal:  Dose Response       Date:  2010-03-18       Impact factor: 2.658

2.  Protective effect of resveratrol on citrullinemia type I-induced brain oxidative damage in male rats.

Authors:  Larissa Delmonego; Thayná Patachini Maia; Débora Delwing-Dal Magro; Karine Louize Vincenzi; Aline Barbosa Lima; Luana Carla Pscheidt; Letícia Eger; Daniela Delwing-de Lima
Journal:  Metab Brain Dis       Date:  2021-02-08       Impact factor: 3.584

3.  trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation.

Authors:  Y Tan; L H K Lim
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

Review 4.  Resveratrol: A Focus on Several Neurodegenerative Diseases.

Authors:  Ester Tellone; Antonio Galtieri; Annamaria Russo; Bruno Giardina; Silvana Ficarra
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

Review 5.  Endothelium and its alterations in cardiovascular diseases: life style intervention.

Authors:  Gaia Favero; Corrado Paganelli; Barbara Buffoli; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

6.  Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress.

Authors:  Yujie Liu; Xizhou Chen; Jie Li
Journal:  Mol Med Rep       Date:  2017-03-09       Impact factor: 2.952

Review 7.  Reversing the immune ageing clock: lifestyle modifications and pharmacological interventions.

Authors:  Niharika A Duggal
Journal:  Biogerontology       Date:  2018-09-29       Impact factor: 4.277

8.  Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice.

Authors:  Young-Eun Lee; Ji-Won Kim; Eun-Mi Lee; Yu-Bae Ahn; Ki-Ho Song; Kun-Ho Yoon; Hyung-Wook Kim; Cheol-Whee Park; Guolian Li; Zhenqi Liu; Seung-Hyun Ko
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Decreased activity and accelerated apoptosis of neutrophils in the presence of natural polyphenols.

Authors:  Viera Jančinová; Tomáš Perečko; Juraj Harmatha; Radomír Nosáľ; Katarína Drábiková
Journal:  Interdiscip Toxicol       Date:  2012-06

10.  Resveratrol Attenuates Staphylococcus Aureus-Induced Monocyte Adhesion through Downregulating PDGFR/AP-1 Activation in Human Lung Epithelial Cells.

Authors:  I-Ta Lee; Chih-Chung Lin; Chien-Chung Yang; Li-Der Hsiao; Ming-Yen Wu; Chuen-Mao Yang
Journal:  Int J Mol Sci       Date:  2018-10-07       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.